mutations and complicated kar yotype. It follows a linear evolution with the CLL clone in the recurrent acquisition of CDKN2AGenetic susceptibility mechanisms. Most susceptibility loci map to non-coding locations on the genome, are primarily situated in active promoters or enhancers, and modify the binding web pages of quite a few transcription ele